Method of treatment for central nervous system diseases such as

Details Method of treatment for central nervous system diseases such as Method of treatment for central nervous system diseases such as

1984-10-29

1988-12-13

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514171, 424108, A61K 3700, A61K 3156, A61K 3555

Patent

active

047910992

ABSTRACT:
A method of treating humans suffering from central nervous system diseases, such as Alzheimer's disease, cerebral atrophy, Parkinson's disease, senile tremor, essential tremor, and cerebellar atrophy, as well as diseases where dementia is present. The treatment consists of inducing into the patient's blood stream at least one from the group consisting of: sex hormones and anabolic hormones. Ergolid myselates may be used in conjunction with the hormone, as well as a vasodilator and non-steroid anti-inflammatory. Growth hormone may also be used in those patients in advanced stages of the disease, or in those patients where it has been determined that a low level of growth hormone is present.

REFERENCES:
patent: 4469707 (1984-09-01), Lindberg
Merck Index (1983), 10th Edition, #8562.
Chemical Abstracts, vol. 86 (1977) #50823s; Cotzias et al.

Affiliated with

Also associated with

Rating

Method of treatment for central nervous system diseases such as does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment for central nervous system diseases such as , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for central nervous system diseases such as will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2196242